VAERS reports by lot

Sanofi Pasteur DTaP/Tdap lot C5222AA: VAERS reports

32 VAERS reports list lot C5222AA as a Sanofi Pasteur DTaP/Tdap vaccine, received between 2017-03-15 and 2019-08-23. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
32
Reports
3%
Marked serious
0
With a death outcome
17
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction4463%
Dermatological (non-injection-site)1217%
Allergic / Anaphylactic57%
Gastrointestinal34%
General / Systemic (non-local)23%
Cardiac / Cardiovascular11%
Thrombotic / Hematological11%
Autoimmune / Immune-mediated11%
Musculoskeletal11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Pennsylvania4
Florida4
Colorado4
Texas3
Michigan3
Oregon3
Massachusetts2
California2
Indiana2
Utah1
Arizona1
Alabama1

Reports by month received

2017-031
2017-052
2017-064
2017-072
2017-087
2017-092
2017-101
2017-111
2018-061
2018-082
2018-091
2018-101
2019-011
2019-031
2019-041
2019-062
2019-082

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.